Cargando…
Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
Achromobacter xylosoxidans can cause chronic infections in the lungs of patients with cystic fibrosis (CF) by adapting to the specific environment. The study of longitudinal isolates allows to investigate its within-host evolution to unravel the adaptive mechanisms contributing to successful coloniz...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168687/ https://www.ncbi.nlm.nih.gov/pubmed/31973169 http://dx.doi.org/10.3390/pathogens9020072 |
_version_ | 1783523696272474112 |
---|---|
author | Veschetti, Laura Sandri, Angela Krogh Johansen, Helle Lleò, Maria M. Malerba, Giovanni |
author_facet | Veschetti, Laura Sandri, Angela Krogh Johansen, Helle Lleò, Maria M. Malerba, Giovanni |
author_sort | Veschetti, Laura |
collection | PubMed |
description | Achromobacter xylosoxidans can cause chronic infections in the lungs of patients with cystic fibrosis (CF) by adapting to the specific environment. The study of longitudinal isolates allows to investigate its within-host evolution to unravel the adaptive mechanisms contributing to successful colonization. In this study, four clinical isolates longitudinally collected from two chronically infected patients underwent whole genome sequencing, de novo assembly and sequence analysis. Phenotypic assays were also performed. The isolates coming from one of the patients (patient A) presented a greater number of genetic variants, diverse integrative and conjugative elements, and different protease secretion. In the first of these isolates (strain A1), we also found a large deletion in the mutS gene, involved in DNA mismatch repair (MMR). In contrast, isolates from patient B showed a lower number of variants, only one integrative and mobilizable element, no phenotypic changes, and no mutations in the MMR system. These results suggest that in the two patients the establishment of a chronic infection was mediated by different adaptive mechanisms. While the strains isolated from patient B showed a longitudinal microevolution, strain A1 can be clearly classified as a hypermutator, confirming the occurrence and importance of this adaptive mechanism in A. xylosoxidans infection. |
format | Online Article Text |
id | pubmed-7168687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71686872020-04-20 Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection Veschetti, Laura Sandri, Angela Krogh Johansen, Helle Lleò, Maria M. Malerba, Giovanni Pathogens Article Achromobacter xylosoxidans can cause chronic infections in the lungs of patients with cystic fibrosis (CF) by adapting to the specific environment. The study of longitudinal isolates allows to investigate its within-host evolution to unravel the adaptive mechanisms contributing to successful colonization. In this study, four clinical isolates longitudinally collected from two chronically infected patients underwent whole genome sequencing, de novo assembly and sequence analysis. Phenotypic assays were also performed. The isolates coming from one of the patients (patient A) presented a greater number of genetic variants, diverse integrative and conjugative elements, and different protease secretion. In the first of these isolates (strain A1), we also found a large deletion in the mutS gene, involved in DNA mismatch repair (MMR). In contrast, isolates from patient B showed a lower number of variants, only one integrative and mobilizable element, no phenotypic changes, and no mutations in the MMR system. These results suggest that in the two patients the establishment of a chronic infection was mediated by different adaptive mechanisms. While the strains isolated from patient B showed a longitudinal microevolution, strain A1 can be clearly classified as a hypermutator, confirming the occurrence and importance of this adaptive mechanism in A. xylosoxidans infection. MDPI 2020-01-21 /pmc/articles/PMC7168687/ /pubmed/31973169 http://dx.doi.org/10.3390/pathogens9020072 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Veschetti, Laura Sandri, Angela Krogh Johansen, Helle Lleò, Maria M. Malerba, Giovanni Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title | Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title_full | Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title_fullStr | Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title_full_unstemmed | Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title_short | Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection |
title_sort | hypermutation as an evolutionary mechanism for achromobacter xylosoxidans in cystic fibrosis lung infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168687/ https://www.ncbi.nlm.nih.gov/pubmed/31973169 http://dx.doi.org/10.3390/pathogens9020072 |
work_keys_str_mv | AT veschettilaura hypermutationasanevolutionarymechanismforachromobacterxylosoxidansincysticfibrosislunginfection AT sandriangela hypermutationasanevolutionarymechanismforachromobacterxylosoxidansincysticfibrosislunginfection AT kroghjohansenhelle hypermutationasanevolutionarymechanismforachromobacterxylosoxidansincysticfibrosislunginfection AT lleomariam hypermutationasanevolutionarymechanismforachromobacterxylosoxidansincysticfibrosislunginfection AT malerbagiovanni hypermutationasanevolutionarymechanismforachromobacterxylosoxidansincysticfibrosislunginfection |